MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with S

Solifenacin

Solifenacin 5mg tablets

Use with caution

Stability notes for Solifenacin 5mg tablets

Protect from moisture.
No stability data in MCAs available.

Provenance

This recommendation is based on the products Vesicare 5mg film-coated tables (Astellas Pharma Ltd) and Solifenacin 5mg film-coated tablets (Aurobindo Pharma – Milpharm Ltd).

Suppliers (20) of Solifenacin 5mg tablets
Solifenacin 5mg tablets (A A H Pharmaceuticals Ltd)
Solifenacin 5mg tablets (Accord-UK Ltd)
Solifenacin 5mg tablets (Alliance Healthcare (Distribution) Ltd)
Solifenacin 5mg tablets (Bristol Laboratories Ltd)
Solifenacin 5mg tablets (Brown & Burk UK Ltd)
Solifenacin 5mg tablets (Crescent Pharma Ltd)
Solifenacin 5mg tablets (Genus Pharmaceuticals Ltd)
Solifenacin 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Solifenacin 5mg tablets (Krka UK Ltd)
Solifenacin 5mg tablets (Medihealth (Northern) Ltd)
Solifenacin 5mg tablets (Medreich Plc)
Solifenacin 5mg tablets (Milpharm Ltd)
Solifenacin 5mg tablets (MSN Laboratories Europe Ltd)
Solifenacin 5mg tablets (Sun Pharma UK Ltd)
Solifenacin 5mg tablets (Tillomed Laboratories Ltd)
Solifenacin 5mg tablets (Umedica Laboratories UK Ltd)
Solifenacin 5mg tablets (Zentiva Pharma UK Ltd)
Vesicare 5mg tablets (Astellas Pharma Ltd)
Vesicare 5mg tablets (CST Pharma Ltd)
Vesicare 5mg tablets (Necessity Supplies Ltd)

Solifenacin 10mg tablets

Use with caution

Stability notes for Solifenacin 10mg tablets

Protect from moisture.
No stability data in MCAs available.

Provenance

This recommendation is based on the products Vesicare 10mg film-coated tables (Astellas Pharma Ltd) and Solifenacin 10mg film-coated tablets (Aurobindo Pharma – Milpharm Ltd).

Suppliers (19) of Solifenacin 10mg tablets
Solifenacin 10mg tablets (A A H Pharmaceuticals Ltd)
Solifenacin 10mg tablets (Accord-UK Ltd)
Solifenacin 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Solifenacin 10mg tablets (Bristol Laboratories Ltd)
Solifenacin 10mg tablets (Brown & Burk UK Ltd)
Solifenacin 10mg tablets (Crescent Pharma Ltd)
Solifenacin 10mg tablets (Genus Pharmaceuticals Ltd)
Solifenacin 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Solifenacin 10mg tablets (Krka UK Ltd)
Solifenacin 10mg tablets (Medihealth (Northern) Ltd)
Solifenacin 10mg tablets (Medreich Plc)
Solifenacin 10mg tablets (Milpharm Ltd)
Solifenacin 10mg tablets (MSN Laboratories Europe Ltd)
Solifenacin 10mg tablets (Sun Pharma UK Ltd)
Solifenacin 10mg tablets (Tillomed Laboratories Ltd)
Solifenacin 10mg tablets (Umedica Laboratories UK Ltd)
Vesicare 10mg tablets (Astellas Pharma Ltd)
Vesicare 10mg tablets (CST Pharma Ltd)
Vesicare 10mg tablets (Necessity Supplies Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.